a provider of advanced technology solutions and services for oncology drugs
Industry Biotechnology
A.I.dvisor tells us that CSBR and LIXT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and LIXT's prices will move in lockstep.
Ticker / NAME | Correlation To CSBR | 1D Price Change % | ||
---|---|---|---|---|
CSBR | 100% | -1.54% | ||
LIXT - CSBR | 25% Poorly correlated | +2.81% | ||
PMN - CSBR | 23% Poorly correlated | -4.11% | ||
ABOS - CSBR | 22% Poorly correlated | -10.58% | ||
LBPH - CSBR | 22% Poorly correlated | -5.74% | ||
LPTX - CSBR | 21% Poorly correlated | -1.38% | ||
More |
Ticker / NAME | Correlation To CSBR | 1D Price Change % |
---|---|---|
CSBR | 100% | -1.54% |
drugs theme (265 stocks) | -0% Poorly correlated | +5.37% |
oncology theme (18 stocks) | -1% Poorly correlated | +0.37% |
biotechnology theme (248 stocks) | -1% Poorly correlated | +5.56% |
cancer theme (87 stocks) | -3% Poorly correlated | +0.89% |
technology theme (33 stocks) | -4% Poorly correlated | +0.06% |